关注
Kaori Yamada
Kaori Yamada
在 uic.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transport of PIP3 by GAKIN, a kinesin-3 family protein, regulates neuronal cell polarity
K Horiguchi, T Hanada, Y Fukui, AH Chishti
The Journal of cell biology 174 (3), 425-436, 2006
1652006
Evidence that a phosphatidylinositol 3, 4, 5-trisphosphate-binding protein can function in nucleus
K Tanaka, K Horiguchi, T Yoshida, M Takeda, H Fujisawa, K Takeuchi, ...
Journal of Biological Chemistry 274 (7), 3919-3922, 1999
1501999
The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN/KIF13B
KH Yamada, T Hanada, AH Chishti
Biochemistry 46 (35), 10039-10045, 2007
892007
Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress
KH Yamada, DA Kozlowski, SE Seidl, S Lance, AJ Wieschhaus, ...
Journal of Biological Chemistry 287 (16), 13182-13193, 2012
812012
Phosphorylation-independent dual-site binding of the FHA domain of KIF13 mediates phosphoinositide transport via centaurin α1
Y Tong, W Tempel, H Wang, K Yamada, L Shen, GA Senisterra, ...
Proceedings of the National Academy of Sciences 107 (47), 20346-20351, 2010
652010
KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2
KH Yamada, Y Nakajima, M Geyer, KK Wary, M Ushio-Fukai, Y Komarova, ...
Journal of cell science 127 (20), 4518-4530, 2014
492014
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
NTT Nhàn, T Yamada, KH Yamada
International Journal of Molecular Sciences 24 (16), 12931, 2023
252023
Antiangiogenic therapeutic potential of peptides derived from the molecular motor KIF13B that transports VEGFR2 to plasmalemma in endothelial cells
KH Yamada, H Kang, AB Malik
The American journal of pathology 187 (1), 214-224, 2017
162017
VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
SB Waters, C Zhou, T Nguyen, R Zelkha, H Lee, A Kazlauskas, ...
Investigative ophthalmology & visual science 62 (2), 5-5, 2021
132021
Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
NTT Nhàn, DE Maidana, KH Yamada
Cells 12 (7), 2023
122023
KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo
SB Waters, JR Dominguez, HD Cho, NA Sarich, AB Malik, KH Yamada
Life Science Alliance 5 (1), 2022
62022
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration
KH Yamada
Neural Regeneration Research 17 (8), 1751-1752, 2022
42022
KIF13B mediates VEGFR2 recycling to modulate vascular permeability
HD Cho, NTT Nhàn, C Zhou, K Tu, T Nguyen, NA Sarich, KH Yamada
Cellular and Molecular Life Sciences 80 (4), 91, 2023
12023
Anti‐angiogenic Peptide Derived from Kinesin KIF13B Inhibits Trafficking of VEGFR2 to Endothelial Cell surface
K Yamada, AB Malik
The FASEB Journal 31, 990.8-990.8, 2017
12017
驱动蛋白源性血管生成抑制剂可选择性抑制 VEGFR2 向细胞表面运输
KH Yamada
中国神经再生研究 (英文版) 17 (8), 1751, 2022
2022
KIF13B-derived peptide and method of inhibiting angiogenesis
K Yamada, A Malik
US Patent 11,299,524, 2022
2022
A kinesin mediates VEGFR2 recycling and regulates VE-cadherin phosphorylation, essential for vascular permeability
HD Cho, C Zhou, K Tu, T Nguyen, NA Sarich, KH Yamada
bioRxiv, 2022.06. 06.494986, 2022
2022
VEGFR2 trafficking by KIF13B is a novel therapeutic target for wet AMD
K Yamada, C Zhou
Investigative Ophthalmology & Visual Science 62 (8), 220-220, 2021
2021
Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells (vol 187, pg 214, 2017)
KH Yamada, H Kang, AB Malik
AMERICAN JOURNAL OF PATHOLOGY 188 (8), 1934-1934, 2018
2018
Role of kinesin-mediated transport of VEGFR2 to the cell surface in mediating angiogenesis.
K Yamada, GF Chen, H Gong, Y Komarova, M Ushio-Fukai, K Wary, ...
MOLECULAR BIOLOGY OF THE CELL 22, 2011
2011
系统目前无法执行此操作,请稍后再试。
文章 1–20